Skip to content
Find a doctor Contact Us
Prescribing Information
Important Safety Information
For Healthcare Professionals
Vevye Logo Vevye Logo Stay Connected

See Results VEVYE® works fast so you can
leave dry eyes behind

See Results VEVYE® works fast so you can
leave dry eyes behind

In just

Days

In just

Days

Patient-Reported Improvement in Dry Eye Symptoms at Day 29

Within a month of starting treatment, patients using VEVYE, 
on average, reported an improvement in:

  • The sensation, frequency, and awareness of dry eyes

  • Blurred and fluctuating vision

  • The ability to read, drive at night, and look at screens

In Clinical Trials:

Day 15

VEVYE started to repair the physical damage caused by dry eye disease.

VEVYE started to repair the physical damage caused by dry eye disease.

Day 29

VEVYE increased natural
tear production.

VEVYE increased natural
tear production.

Month 12

Patients using VEVYE, on average, were nearly back to normal, healthy tear production levels.

Patients using VEVYE, on average, were nearly back to normal, healthy tear production levels.

VEVYE starts working fast

Bringing you relief from symptoms such as burning, stinging, and itching within the first month.

Tough on dry eye.

Gentle on Your Eyes.

VEVYE has a unique formulation that reduces stinging and irritation for a dry eye treatment you can stick with.

VEVYE has a unique formulation that reduces stinging and irritation for a dry eye treatment you can stick with.

In Clinical Trials:

99.8% of patients

reported mild to no pain
when applying VEVYE

reported mild to no pain
when applying VEVYE

Side effects were mild in most cases

The most common side effects were mild eye irritation (8%) and temporary decreases in clarity of vision (3%)

The most common side effects were mild eye irritation (8%) and temporary decreases in clarity of vision (3%)

In a 12-month study only one
Patient

stopped using VEVYE, due
to a side effect, mild burning/stinging

stopped using VEVYE, due
to a side effect, mild burning/stinging

Savings Made Simple

With the VEVYE Savings Program, commercially insured patients may  pay as little as $0!*

Learn More

*For patients whose prescriptions are covered by commercial insurance, the VEVYE Savings Program may reduce your copayment so that you may pay as little as $0. For patients whose prescriptions are not covered by commercial insurance, the VEVYE Savings Program may reduce your cost for prescriptions to as little as $79. For complete Terms and Conditions, visit: getvevye.com

INDICATION AND USAGE

VEVYE (cyclosporine ophthalmic solution) 0.1% is a prescription drop used to treat the signs and symptoms of dry eye disease.

IMPORTANT SAFETY INFORMATION

  • To avoid the potential for eye injury and/or contamination, do not touch the bottle tip to the eye or other surfaces.
  • VEVYE should not be administered while wearing contact lenses. Remove contacts prior to using VEVYE. After applying VEVYE to the eyes wait 15 minutes before reinserting contact lenses.
  • The most common side effects include eye irritation (8%) and temporary blurred vision (3%).

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
For additional information about VEVYE, please see the Full Prescribing Information.

INDICATION AND USAGE

VEVYE (cyclosporine ophthalmic solution) 0.1% is a prescription drop used to treat the signs and symptoms of dry eye disease.

IMPORTANT SAFETY INFORMATION

  • To avoid the potential for eye injury and/or contamination, do not touch the bottle tip to the eye or other surfaces.
  • VEVYE should not be administered while wearing contact lenses. Remove contacts prior to using VEVYE. After applying VEVYE to the eyes wait 15 minutes before reinserting contact lenses.
  • The most common side effects include eye irritation (8%) and temporary blurred vision (3%).

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.


For additional information about VEVYE, please see the Full Prescribing Information.